CS
LJPC

Credit Suisse’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Credit Suisse’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,757
Closed -$99K – 4401
2019
Q2 		$99K Sell
10,757
-4,306
-29% -$32.5K ﹤0.01% 3952
2019
Q1 		$96K Sell
15,063
-574
-4% -$3.74K ﹤0.01% 3848
2018
Q4 		$147K Sell
15,637
-27,909
-64% -$420K ﹤0.01% 3724
2018
Q3 		$877K Buy
43,546
+26,499
+155% +$693K ﹤0.01% 2956
2018
Q2 		$497K Buy
17,047
+10
+0.1% +$309 ﹤0.01% 3425
2018
Q1 		$507K Buy
17,037
+182
+1% +$5.87K ﹤0.01% 3356
2017
Q4 		$541K Sell
16,855
-10,570
-39% -$345K ﹤0.01% 3395
2017
Q3 		$954K Sell
27,425
-4,675
-15% -$150K ﹤0.01% 3138
2017
Q2 		$956K Buy
32,100
+19,017
+145% +$545K ﹤0.01% 2733
2017
Q1 		$391K Buy
+13,083
New +$334K ﹤0.01% 3423
2016
Q4 		– Sell
-11,659
Closed -$277K – 4402
2016
Q3 		$277K Sell
11,659
-21,082
-64% -$397K ﹤0.01% 3686
2016
Q2 		$524K Buy
+32,741
New +$587K ﹤0.01% 3397
2016
Q1 		– Sell
-12,768
Closed -$344K – 4580
2015
Q4 		$344K Sell
12,768
-34,762
-73% -$948K ﹤0.01% 3620
2015
Q3 		$1.32M Buy
+47,530
New +$1.5M ﹤0.01% 2575
2014
Q2 		– Sell
-18,437
Closed -$199K – 5034
2014
Q1 		$199K Buy
+18,437
New +$181K ﹤0.01% 4354

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Credit Suisse's LJPC Position: Q3 2019 in Review

Credit Suisse sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2019, closing a stake of 10,757 shares — an estimated $99K sold.

Credit Suisse first reported a position in LJPC in Q1 2014 and held it in 15 quarters. The position peaked at $1.32M in Q3 2015. 75 funds tracked by Wall St. Rank hold LJPC as of Q3 2019.

  • Credit Suisse reported no remaining La Jolla Pharmaceutical Company position as of Q3 2019 after selling out during the quarter.
  • Credit Suisse sold 10,757 La Jolla Pharmaceutical Company shares in Q3 2019, an estimated $99K.
  • Credit Suisse first reported a position in La Jolla Pharmaceutical Company in Q1 2014 and held it in 15 quarters.
  • Credit Suisse's La Jolla Pharmaceutical Company position peaked at $1.32M in Q3 2015.
  • 75 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2019.

Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.